ClinicalTrials.gg
Not yet recruitingNCT02294799MRITMJUpdated Feb 28, 2025

Magnetic Ressonance Imaging of Temporomandibular Joint

An interventional study of Intervention Group and Placebo group in Temporomandibular Joint Dysfunction, sponsored by Daniela Ap. Biasotto-Gonzalez. Not yet recruiting at 1 site in Brazil. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-02-28.

Sponsored by Daniela Ap. Biasotto-Gonzalez · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Temporomandibular Joint Disorders with a site in Brazil — 7 open to participants now, 7 under way, none of them phase 3. Temporomandibular Joint Disorders · Brazil.

Planned enrollment
28th of 36
24 · median 40
Started
2026
the only one that year
No phase
28 of 44
5 open now
Registered
11th of 44
by date
Lead sponsor
2 of 44
Daniela Ap. Biasotto-Gonzalez

Among the 44 studies in Temporomandibular Joint Disorders with a site in Brazil, this one is the 28th largest by planned enrollment of the 36 interventional ones that give a count, is the only one that started in 2026, is one of 28 with no phase, and was the 11th registered.

Temporomandibular Joint Disorders

593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

Browse Temporomandibular Joint Disorders studies →

Open to participants now

7 of the 44 studies in Temporomandibular Joint Disorders with a site in Brazil are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Temporomandibular Joint Disorders with a site in Brazil, or all of them as a file.
02

Study summary

Background: Among the instrumental devices that have been proposed over the years to integrate the clinical evaluation of temporomandibular joint disorders (TMD), imaging techniques are the most studied, showing that magnetic resonance imaging (MRI) is the technique most need to describe the anatomy of the TMJ and to evaluate the correlation of imaging findings with the clinical diagnosis . Despite the amount available studies on the use of MRI for evaluation of TMJ disorders and treatments, there is a lack of studies that evaluate the imaging findings after physical therapy. Purpose: To evaluate the influence of nonspecific mandibular mobilization about the positioning of the articular disc by MRI in individuals with TMD diagnosis of anterior disc displacement with and without reduction according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). Analyze the behavior of pain through the numerical scale of pain assessment (END) at baseline and after each treatment session, the quality of life of individuals with TMD at baseline, immediately, three and six months after the treatment sessions by the World Health Organization Quality of Life Assessment (WHOQOL - BREF), and The Patient's Specific Functional Scale (PSFS) at baseline and after treatment. The treatment will be performed three times a week during four weeks. Metodology: This is a randomized, placebo controlled, blind study designed to assess the effects of techniques nonspecific mandibular mobilization x placebo. Individuals will be randomized and divided into two groups: Group A (intervention) and Group B (placebo). Statistic analysis: The positioning of the articular disc, extracted through the use of MRI, will be considered the primary outcome and, as a secondary outcome will be assessed the quality of life, pain and function after treatment. The adherence of the data to a Gaussian curve will be verified by the Shapiro-Wilk and the data are expressed as mean values and standard deviation. Two-way repeated measures analysis of variance with Bonferroni post hoc test will be used for inter-and intra-group comparisons. The significance level is adjusted p ≤ 0.05.

Read the detailed description

This is a randomized, placebo-controlled, double-blind study designed to verify the effects of nonspecific mandibular mobilization techniques x placebo

03

Conditions studied

  • Temporomandibular Joint Dysfunction

Keywords

  • Temporomandibular Joint Disorders
  • Magnetic Ressonance Imaging
  • Complementary Therapy
  • Physical Therapy Modalities.
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • TMD diagnosed subjects by RDC / TMD confirmed by the MRI findings,
  • with anterior disk displacement with or without reduction,
  • with full dentition (excluding third molars).

Exclusion criteria

Exclusion Criteria:

  • Subjects diagnosed TMD exclusively muscular;
  • with posterior and / or medial displacement of the disc;
  • showing systemic diseases that affect the joints and / or masticatory muscles;
  • neuromuscular diseases;
  • hypo / condylar hyperplasia;
  • making use of any type of dental prosthesis;
  • are in orthodontic and / or physical therapy;
  • showing neurological or behavioral disorders that preclude the achievement of MRI and/or
  • a history of previous TMJ surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Other
    Intervention Group

    TMD diagnosed sujects that will receive the mobilization treatment

    Other: Intervention Group

  • Placebo comparator
    Placebo Group

    TMD diagnosed sujects that will receive the placebo treatment

    Other: Placebo group

Interventions

  • OtherIntervention Group

    Grade 1, Nonspecific Mandibular Mobilization

    Also known as: Mandibular Mobilization

  • OtherPlacebo group

    Nonspecific Mandibular Movement.

    Also known as: Placebo Mandibular Mobilization

06

What researchers measure

Primary outcomes

  1. Articular Disc Positioning (Measured by the Magnetic Ressonance Imaging)

    Measured by the Magnetic Ressonance Imaging

    Time frame: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.

Secondary outcomes

  1. Clinical Symptoms (Measured by END)

    Measured by numerical scale of pain assessment (END)

    Time frame: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.

  2. Functionality (Mesuread by "The Patient´s Specific Funcional Scale - HORN, 2012)

    Mesuread by "The Patient´s Specific Funcional Scale - HORN, 2012

    Time frame: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.

  3. Quality of life (Whoqol-bref)

    Whoqol-bref

    Time frame: Baseline (day 1) and after 4 weeks of treatment (performed 3 times a week), 3 and 6 months follow up

07

Study locations

1 site
08

References and documents

Publications

  • Ahmad M, Hollender L, Anderson Q, Kartha K, Ohrbach R, Truelove EL, John MT, Schiffman EL. Research diagnostic criteria for temporomandibular disorders (RDC/TMD): development of image analysis criteria and examiner reliability for image analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jun;107(6):844-60. doi: 10.1016/j.tripleo.2009.02.023. PubMed 19464658 ↗
  • de Lucena LB, Kosminsky M, da Costa LJ, de Goes PS. Validation of the Portuguese version of the RDC/TMD Axis II questionnaire. Braz Oral Res. 2006 Oct-Dec;20(4):312-7. doi: 10.1590/s1806-83242006000400006. PubMed 17242791 ↗
  • Gray RJ, Quayle AA, Hall CA, Schofield MA. Physiotherapy in the treatment of temporomandibular joint disorders: a comparative study of four treatment methods. Br Dent J. 1994 Apr 9;176(7):257-61. doi: 10.1038/sj.bdj.4808429. PubMed 8186034 ↗
  • Furto ES, Cleland JA, Whitman JM, Olson KA. Manual physical therapy interventions and exercise for patients with temporomandibular disorders. Cranio. 2006 Oct;24(4):283-91. doi: 10.1179/crn.2006.044. PubMed 17086858 ↗
  • Ohnuki T, Fukuda M, Nakata A, Nagai H, Takahashi T, Sasano T, Miyamoto Y. Evaluation of the position, mobility, and morphology of the disc by MRI before and after four different treatments for temporomandibular joint disorders. Dentomaxillofac Radiol. 2006 Mar;35(2):103-9. doi: 10.1259/dmfr/25020275. PubMed 16549437 ↗
  • Horn KK, Jennings S, Richardson G, Vliet DV, Hefford C, Abbott JH. The patient-specific functional scale: psychometrics, clinimetrics, and application as a clinical outcome measure. J Orthop Sports Phys Ther. 2012 Jan;42(1):30-42. doi: 10.2519/jospt.2012.3727. Epub 2011 Oct 25. PubMed 22031594 ↗
  • Aigner M, Forster-Streffleur S, Prause W, Freidl M, Weiss M, Bach M. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psychiatr Epidemiol. 2006 Jan;41(1):81-6. doi: 10.1007/s00127-005-0997-8. Epub 2006 Jan 1. PubMed 16341612 ↗
  • El Hage Y, Politti F, de Sousa DF, Herpich CM, Gloria IP, Gomes CA, Amaral AP, de Melo NC, da Silva TC, Arruda EE, Amorim CF, Gadotti IC, Gonzalez TO, Berzin F, Bussadori SK, Garcia MB, Barbosa BR, Biasotto-Gonzalez DA. Effect of mandibular mobilization on electromyographic signals in muscles of mastication and static balance in individuals with temporomandibular disorder: study protocol for a randomized controlled trial. Trials. 2013 Oct 1;14:316. doi: 10.1186/1745-6215-14-316. PubMed 24083628 ↗
  • Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011 Oct;152(10):2399-2404. doi: 10.1016/j.pain.2011.07.005. PubMed 21856077 ↗
  • Emshoff R, Brandlmaier I, Gerhard S, Strobl H, Bertram S, Rudisch A. Magnetic resonance imaging predictors of temporomandibular joint pain. J Am Dent Assoc. 2003 Jun;134(6):705-14. doi: 10.14219/jada.archive.2003.0256. PubMed 12839406 ↗
  • Emara AS, Faramawey MI, Hassaan MA, Hakam MM. Botulinum toxin injection for management of temporomandibular joint clicking. Int J Oral Maxillofac Surg. 2013 Jun;42(6):759-64. doi: 10.1016/j.ijom.2013.02.009. Epub 2013 Mar 26. PubMed 23538215 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Dec 2027, 16 months later.

Of 244 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's planned 16 months is above that.

Counting every sponsor, half of 248 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 9, 2013
First posted
Nov 19, 2014
StartEst.
Aug 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2028
Last update
Feb 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02294799
Lead sponsor
Daniela Ap. Biasotto-Gonzalez
Responsible party
Daniela Ap. Biasotto-Gonzalez (Phd, University of Nove de Julho) — Sponsor-investigator
First posted
Nov 19, 2014
Start date
Aug 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2028 (estimated)
Last update
Feb 28, 2025

Study contacts

DANIELA AP BIASOTTO-GONZALEZ, PHD
Contact
dani_atm@ig.com.br
+55 11 36659325
Daniela Ap Biasotto-Gonzalez, PHD
principal investigator · University of Nove de Julho

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion